For patients with terminal cancer, chemotherapy does not improve quality of life
the ONA take:
Chemotherapy administered to patients with cancer who are near death does not improve quality of life and may even reduce quality of life in those who have good performance status, a recent study published in JAMA Oncology has shown.
For the study, researchers evaluated 312 patients with terminal cancer who were estimated to live no more than 6 months. The majority were receiving chemotherapy. Results showed that patients with a poor performance status who received chemotherapy achieved no improvement in quality of life during their final week prior to death.
Moreover, researchers found that in those with a good performance status, treatment worsened their quality of life compared with patients with a good performance status who were not receiving treatment.
Current American Society of Clinical Oncology (ASCO) guidelines contend that patients with terminal cancer and a good performance status are the most likely to benefit from chemotherapy, but these findings suggest that chemotherapy given to patients at the end of life may be wasteful, unnecessary, and potentially harmful.
Chemotherapy administered to patients with cancer who are near death does not improve quality of life.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|